Article

Targeted therapies inhibit PCa bone metastasis

San Francisco-Prostate cancer bone metastases appear to react favorablyto treatment with a new bisphosphonate and the tyrosine-kinase inhibitorsPKI-166 and STI-571, according to studies presented at the American Associationfor Cancer Research annual meeting here.

Related Videos
Yahir A. Santiago-Lastra, MD, answers a question during a Zoom video interview
Woman talking with a doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
Karyn S. Eilber, MD, answers a question during a Zoom video interview
Anna Myers, CNP, answers a question during a Zoom video interview
Drug costs | Image Credit: © pixelrobot - stock.adobe.com
Raymond Xu, MD, answers a question during a Zoom video interview
Related Content
© 2025 MJH Life Sciences

All rights reserved.